258 related articles for article (PubMed ID: 18505083)
41. Abrogation of the negative influence of opioids on IL-2 immunotherapy of renal cell cancer by melatonin.
Lissoni P; Mandalà M; Brivio F
Eur Urol; 2000 Jul; 38(1):115-8. PubMed ID: 10859453
[TBL] [Abstract][Full Text] [Related]
42. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
[TBL] [Abstract][Full Text] [Related]
43. Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer.
Lissoni P; Tisi E; Barni S; Ardizzoia A; Rovelli F; Rescaldani R; Ballabio D; Benenti C; Angeli M; Tancini G
Br J Cancer; 1992 Jul; 66(1):155-8. PubMed ID: 1322155
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of the concomitant administration of the pineal hormone melatonin in cancer immunotherapy with low-dose IL-2 in patients with advanced solid tumors who had progressed on IL-2 alone.
Lissoni P; Barni S; Cazzaniga M; Ardizzoia A; Rovelli F; Brivio F; Tancini G
Oncology; 1994; 51(4):344-7. PubMed ID: 8208518
[TBL] [Abstract][Full Text] [Related]
45. Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas.
Lissoni P; Barni S; Ardizzoia A; Tancini G
Oncol Rep; 1997; 4(1):157-9. PubMed ID: 21590033
[TBL] [Abstract][Full Text] [Related]
46. The pineal hormone melatonin in hematology and its potential efficacy in the treatment of thrombocytopenia.
Lissoni P; Tancini G; Barni S; Paolorossi F; Rossini F; Maffé P; Di Bella L
Recenti Prog Med; 1996 Dec; 87(12):582-5. PubMed ID: 9066251
[TBL] [Abstract][Full Text] [Related]
47. Cancer as the main aging factor for humans: the fundamental role of 5-methoxy-tryptamine in reversal of cancer-induced aging processes in metabolic and immune reactions by non-melatonin pineal hormones.
Lissoni P; Messina G; Rovelli F
Curr Aging Sci; 2012 Dec; 5(3):231-5. PubMed ID: 23451999
[TBL] [Abstract][Full Text] [Related]
48. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status.
Lissoni P; Barni S; Mandalà M; Ardizzoia A; Paolorossi F; Vaghi M; Longarini R; Malugani F; Tancini G
Eur J Cancer; 1999 Nov; 35(12):1688-92. PubMed ID: 10674014
[TBL] [Abstract][Full Text] [Related]
49. [Chemotherapy of gastrointestinal carcinomas and non-small-cell pulmonary carcinoma: a controversy].
Fey MF; Sauter C; Alberto P
Schweiz Med Wochenschr; 1996 May; 126(20):872-8. PubMed ID: 8685683
[TBL] [Abstract][Full Text] [Related]
50. Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems.
Lissoni P; Messina G; Brivio F; Rovelli F; Di Fede G; Mainini E; Veronese E
J Biol Regul Homeost Agents; 2005; 19(3-4):141-4. PubMed ID: 16602629
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasms.
Lissoni P; Ardizzoia A; Barni S; Brivio F; Tisi E; Rovelli F; Tancini G; Maestroni G; Fumagalli L
Oncol Rep; 1995 Nov; 2(6):1063-8. PubMed ID: 21597854
[TBL] [Abstract][Full Text] [Related]
52. The importance of spirituality in supportive care.
Messina G; Anania S; Bonomo C; Veneroni L; Andreoli A; Mameli F; Ortolina C; De Fabritiis P; Gaffuri M; Imbesi F; Moja E
Int J Yoga; 2011 Jan; 4(1):33-8. PubMed ID: 21654973
[TBL] [Abstract][Full Text] [Related]
53. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
Lissoni P; Brivio F; Fumagalli L; Messina G; Secreto G; Romelli B; Fumagalli G; Rovelli F; Colciago M; Brera G
In Vivo; 2007; 21(4):647-50. PubMed ID: 17708360
[TBL] [Abstract][Full Text] [Related]
54. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients.
Lissoni P; Barni S; Tancini G; Rovelli F; Ardizzoia A; Conti A; Maestroni GJ
Oncology; 1993; 50(6):399-402. PubMed ID: 8233281
[TBL] [Abstract][Full Text] [Related]
55. Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone.
Lissoni P; Cazzaniga M; Tancini G; Scardino E; Musci R; Barni S; Maffezzini M; Meroni T; Rocco F; Conti A; Maestroni G
Eur Urol; 1997; 31(2):178-81. PubMed ID: 9076462
[TBL] [Abstract][Full Text] [Related]
56. A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia.
Lissoni P; Barni S; Brivio F; Rossini F; Fumagalli L; Ardizzoia A; Tancini G
Oncology; 1995; 52(5):360-2. PubMed ID: 7637951
[TBL] [Abstract][Full Text] [Related]
57. A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.
Viganò D; Lissoni P; Rovelli F; Roselli MG; Malugani F; Gavazzeni C; Conti A; Maestroni G
Neuro Endocrinol Lett; 2001 Apr; 22(2):137-41. PubMed ID: 11335890
[TBL] [Abstract][Full Text] [Related]
58. [The studies of melatonin values in the cerebrospinal fluid of hydrocephalic patients].
Kurisaka M; Miyake H; Eghwrudjakpor PO; Mori K
No To Shinkei; 1991 Jul; 43(7):631-6. PubMed ID: 1910947
[TBL] [Abstract][Full Text] [Related]
59. Pineal-opioid system interactions in the control of immunoinflammatory responses.
Lissoni P; Barni S; Tancini G; Fossati V; Frigerio F
Ann N Y Acad Sci; 1994 Nov; 741():191-6. PubMed ID: 7825805
[TBL] [Abstract][Full Text] [Related]
60. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.
Persson C; Glimelius B; Rönnelid J; Nygren P
Nutrition; 2005 Feb; 21(2):170-8. PubMed ID: 15723745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]